InvestorsHub Logo
Followers 80
Posts 24708
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Wednesday, 01/03/2018 7:57:48 AM

Wednesday, January 03, 2018 7:57:48 AM

Post# of 27626
TRVN - 1.80 Pre-market now at 2.17/2.19

Trevena Announces FDA Acceptance for Review of New Drug Application for OLINVO™ (oliceridine) Injection




Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.